SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era
Recruiting
- Conditions
- HIV Infections
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 2500
- Registration Number
- NCT00187512
- Locations
- ๐บ๐ธ
San Francisco General Hospital, San Francisco, California, United States
Natural History of Hepatitis C in Patients With Normal Liver Tests
Completed
- Conditions
- Chronic Hepatitis C
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2024-01-12
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 92
- Registration Number
- NCT00187473
Phosphate Intake's Effect on the Skeletal System - Pilot
Not Applicable
Completed
- Conditions
- Kidney Failure, ChronicHealthy
- Interventions
- Behavioral: dietary phosphorus
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2013-10-09
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 27
- Registration Number
- NCT00187629
- Locations
- ๐บ๐ธ
University of California, San Francisco, California, United States
Placebo Controlled Study of Antibiotic Treatment of Soft Tissue Infection
Not Applicable
Completed
- Conditions
- Soft Tissue Infections
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2015-05-07
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 500
- Registration Number
- NCT00187759
- Locations
- ๐บ๐ธ
San Francisco General Hospital, San Francisco, California, United States
Effect of, OAT3, on the Renal Secretion of Cefotaxime
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2014-10-29
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 24
- Registration Number
- NCT00187655
Child-Parent Psychotherapy for Preschooler Witnesses of Domestic Violence Program
Phase 3
Completed
- Conditions
- Domestic Violence Exposure
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2013-09-19
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 60
- Registration Number
- NCT00187772
- Locations
- ๐บ๐ธ
Child Trauma Research Project, San Francisco, California, United States
Genetic Basis for Variation in the Renal Elimination of Metformin
Phase 4
Completed
- Conditions
- Other Conditions That May Be A Focus of Clinical Attention
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2013-01-10
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 23
- Registration Number
- NCT00187720
- Locations
- ๐บ๐ธ
San Francisco General Hospital, San Francisco, California, United States
Organic Cation Transporter 1 (OCT1), on Response to Metformin in Healthy Subjects
Phase 4
Completed
- Conditions
- Other Conditions That May Be A Focus of Clinical Attention
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2013-01-08
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 20
- Registration Number
- NCT00187681
- Locations
- ๐บ๐ธ
San Francisco General Hospital, San Francsico, California, United States
Impact of Genetics on Metformin Pharmacokinetics
Not Applicable
Completed
- Conditions
- Other Conditions That May Be A Focus of Clinical Attention
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2012-09-25
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 24
- Registration Number
- NCT00187798
- Locations
- ๐บ๐ธ
University of California San Francsico, San Francisco, California, United States
Influence of OCTN2 Variants on Carnitine Status and Plasma Triglycerides
Completed
- Conditions
- Carnitine Transporter Deficiency
- Interventions
- Other: Fasting blood and urine collection
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2012-09-13
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 16
- Registration Number
- NCT00187733
- Locations
- ๐บ๐ธ
San Francisco General Hospital, San Francisco, California, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath